MX9602993A - Hormona del crecimiento humano. - Google Patents

Hormona del crecimiento humano.

Info

Publication number: MX9602993A
Authority: MX; Mexico
Prior art keywords: growth hormone; human growth; human; variants; present
Prior art date: 1994-01-27

Application number

MX9602993A

Other languages

English (en)

Spanish (es)

Inventor

Craig A Rosen

Timothy A Coleman

Mark D Adams

Jeanine D Gocayne

Original Assignee

Human Genome Sciences Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-01-27

Filing date

1995-01-27

Publication date

1997-05-31

1995-01-27 Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc

1997-05-31 Publication of MX9602993A publication Critical patent/MX9602993A/es

Links

102000002265 Human Growth Hormone Human genes 0.000 title abstract 4
108010000521 Human Growth Hormone Proteins 0.000 title abstract 4
239000000854 Human Growth Hormone Substances 0.000 title abstract 4
102000018997 Growth Hormone Human genes 0.000 abstract 2
108010051696 Growth Hormone Proteins 0.000 abstract 2
239000000122 growth hormone Substances 0.000 abstract 2
238000000034 method Methods 0.000 abstract 2
108020004414 DNA Proteins 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
108020004511 Recombinant DNA Proteins 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
238000004519 manufacturing process Methods 0.000 abstract 1
108091033319 polynucleotide Proteins 0.000 abstract 1
239000002157 polynucleotide Substances 0.000 abstract 1
102000040430 polynucleotide Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1
230000009614 wildtype growth Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Oncology (AREA)
Molecular Biology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Obesity (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Zoology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Tropical Medicine & Parasitology (AREA)
AIDS & HIV (AREA)
Physical Education & Sports Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

MX9602993A 1994-01-27 1995-01-27 Hormona del crecimiento humano. MX9602993A (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US08/187,756 US5597709A (en)	1994-01-27	1994-01-27	Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
PCT/US1995/001130 WO1995020398A1 (fr)	1994-01-27	1995-01-27	Hormone de croissance humaine

Publications (1)

Publication Number	Publication Date
MX9602993A true MX9602993A (es)	1997-05-31

Family

ID=22690337

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9602993A MX9602993A (es)	1994-01-27	1995-01-27	Hormona del crecimiento humano.

Country Status (9)

Country	Link
US (3)	US5597709A (fr)
EP (1)	EP0741578A4 (fr)
JP (2)	JPH09508522A (fr)
CN (1)	CN1142188A (fr)
AU (1)	AU681260B2 (fr)
CA (1)	CA2182205A1 (fr)
MX (1)	MX9602993A (fr)
NZ (1)	NZ281761A (fr)
WO (1)	WO1995020398A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5597709A (en) *	1994-01-27	1997-01-28	Human Genome Sciences, Inc.	Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
US6812327B1 (en)	1996-10-25	2004-11-02	Human Genome Sciences, Inc.	Neutrokine-alpha polypeptides
US8212004B2 (en)	1999-03-02	2012-07-03	Human Genome Sciences, Inc.	Neutrokine-alpha fusion proteins
JP2003521865A (ja) *	1997-10-24	2003-07-22	ヒューマンジノームサイエンシーズ，インコーポレイテッド	１４８個のヒト分泌タンパク質
US6696063B1 (en) *	1998-12-30	2004-02-24	Applied Research Systems Ars Holding N.V.	Treatment of HIV-associated dysmorphia/dysmetabolic syndrome (HADDS) with or without lipodystrophy
US6946265B1 (en)	1999-05-12	2005-09-20	Xencor, Inc.	Nucleic acids and proteins with growth hormone activity
KR100348249B1 (ko) *	1999-10-08	2002-08-09	엘지전자 주식회사	가상 채널 테이블 데이터 구조 및 부가 정보 송수신 방법
GB9924351D0 (en)	1999-10-14	1999-12-15	Brennan Frank	Immunomodulation methods and compositions
SE0000837D0 (sv) *	2000-03-13	2000-03-13	Pharmacia & Upjohn Ab	New use
PT2281843T (pt)	2000-06-16	2017-01-02	Human Genome Sciences Inc	Anticorpos que se ligam imunoespecificamente a blys
US7879328B2 (en)	2000-06-16	2011-02-01	Human Genome Sciences, Inc.	Antibodies that immunospecifically bind to B lymphocyte stimulator
AU2001288301A1 (en)	2000-08-18	2002-03-04	Human Genome Sciences, Inc.	Binding polypeptides and methods based thereon
EP1295938A1 (fr) *	2001-09-21	2003-03-26	GenOdyssee	Sequence corrigée du gene hGH-V et un variant allélique
AU2002327824A1 (en) *	2001-06-07	2002-12-23	Genodyssee	Identification of snps the hgv-v gene
ES2411007T3 (es)	2001-10-10	2013-07-04	Novo Nordisk A/S	Remodelación y glicoconjugación de péptidos
DE60332358D1 (de) *	2002-09-09	2010-06-10	Hanall Pharmaceutical Co Ltd	Protease-resistente modifizierte interferon alpha polypeptide
GB0229850D0 (en) *	2002-12-20	2003-01-29	Ares Trading Sa	Splice variant
US20060134736A1 (en) *	2003-03-28	2006-06-22	Jacobs John W	Human growth hormone conjugated with biocompatible polymer
US20050281778A1 (en) *	2003-03-28	2005-12-22	Myung-Ok Park	Human growth hormone conjugated with biocompatible polymer
CA2530725A1 (fr) *	2003-03-28	2004-10-07	Biopolymed Inc.	Materiau biologiquement actif conjugue avec un polymere biocompatible avec un complexe 1:1, technique de preparation de celui-ci et composition pharmaceutique comprenant celui-ci
US20050191649A1 (en) *	2003-10-23	2005-09-01	Illumigen Biosciences, Inc.	Detection of mutations in a gene associated with resistance to viral infection, OAS1
CN1910293B (zh) *	2003-10-23	2011-04-13	伊洛默格生物科学公司	检测与抗病毒感染性有关的基因oas1中的突变的方法
BRPI0507169A (pt)	2004-02-02	2007-06-26	Ambrx Inc	polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
CN1953992A (zh) *	2004-06-23	2007-04-25	Usv有限公司	源自胎盘和脑垂体同种型的嵌合体人生长激素和获得所述嵌合体的方法
US7998930B2 (en)	2004-11-04	2011-08-16	Hanall Biopharma Co., Ltd.	Modified growth hormones
BRPI0519430A2 (pt) *	2004-12-22	2009-02-10	Ambrx Inc	hormânio do crescimento humano modificado
CN103520735B (zh) *	2004-12-22	2015-11-25	Ambrx公司	包含非天然编码的氨基酸的人生长激素配方
EP1836316A4 (fr)	2004-12-22	2009-07-22	Ambrx Inc	Procédés pour l'expression et la purification d'hormone de croissance humaine recombinante
UA95446C2 (ru) *	2005-05-04	2011-08-10	Іллюміджен Байосайєнсіз, Інк.	Мутаци в генах oas1
WO2007005995A2 (fr) *	2005-07-05	2007-01-11	Emisphere Technologies, Inc.	Compositions pour administration par voie buccale de l'hormone de croissance humaine
US9168286B2 (en)	2005-10-13	2015-10-27	Human Genome Sciences, Inc.	Methods and compositions for use in treatment of patients with autoantibody positive disease
WO2007123765A2 (fr)	2006-03-31	2007-11-01	Human Genome Sciences Inc.	NEUTROKINE-ALPHA et variant d'epissage de la neutrokine-alpha
US8637637B2 (en)	2010-01-12	2014-01-28	Bill Nai-Chau Sun	Fc fusion proteins of human growth hormone
WO2011103325A1 (fr)	2010-02-17	2011-08-25	Elona Biotechnologies	Hgh et procédés de préparation de hgh

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL130516C (fr) *	1966-11-08
GB2091739B (en) *	1981-01-27	1984-08-01	Pulblic Helth Lab Service Boar	Purification of human growth hormone
US4446235A (en) *	1982-03-22	1984-05-01	Genentech, Inc.	Method for cloning human growth hormone varient genes
US4670393A (en) *	1982-03-22	1987-06-02	Genentech, Inc.	DNA vectors encoding a novel human growth hormone-variant protein
US4816439A (en) *	1987-03-27	1989-03-28	Nordiske Gentofte A/S	The use of human growth hormone for the treatment of intoxicated individuals
JPH06503479A (ja) *	1991-10-16	1994-04-21	オラージェン，　インコーポレイテッド	動物体細胞の粒子−媒介トランスフォーメーション
US5597709A (en) *	1994-01-27	1997-01-28	Human Genome Sciences, Inc.	Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)

1994
- 1994-01-27 US US08/187,756 patent/US5597709A/en not_active Expired - Lifetime
1995
- 1995-01-27 CN CN95191875A patent/CN1142188A/zh active Pending
- 1995-01-27 NZ NZ281761A patent/NZ281761A/en not_active IP Right Cessation
- 1995-01-27 MX MX9602993A patent/MX9602993A/es not_active Application Discontinuation
- 1995-01-27 EP EP95910890A patent/EP0741578A4/fr not_active Withdrawn
- 1995-01-27 WO PCT/US1995/001130 patent/WO1995020398A1/fr not_active Ceased
- 1995-01-27 AU AU18685/95A patent/AU681260B2/en not_active Ceased
- 1995-01-27 JP JP7520206A patent/JPH09508522A/ja not_active Withdrawn
- 1995-01-27 CA CA002182205A patent/CA2182205A1/fr not_active Abandoned
1996
- 1996-09-16 US US08/710,324 patent/US5962411A/en not_active Expired - Lifetime
1999
- 1999-10-04 US US09/411,657 patent/US6566328B1/en not_active Expired - Fee Related
2002
- 2002-01-28 JP JP2002018215A patent/JP2002300893A/ja not_active Withdrawn

Also Published As

Publication number	Publication date
JPH09508522A (ja)	1997-09-02
US5597709A (en)	1997-01-28
WO1995020398A1 (fr)	1995-08-03
EP0741578A1 (fr)	1996-11-13
CN1142188A (zh)	1997-02-05
US6566328B1 (en)	2003-05-20
CA2182205A1 (fr)	1995-08-03
NZ281761A (en)	1997-11-24
AU681260B2 (en)	1997-08-21
AU1868595A (en)	1995-08-15
US5962411A (en)	1999-10-05
JP2002300893A (ja)	2002-10-15
EP0741578A4 (fr)	1998-05-20

Legal Events

Date	Code	Title	Description
2014-02-28	FA	Abandonment or withdrawal

Publication	Publication Date	Title
MX9602993A (es)	1997-05-31	Hormona del crecimiento humano.
KR970000808B1 (en)	1997-01-20	Human proapolipoprotein a-1 expression
IL142989A0 (en)	2002-04-21	Nucleotide and protein sequences of nogo genes and methods based thereon
NZ271756A (en)	1998-02-26	Human macrophage inflammatory proteins and coding sequences, their production and use
UA13321A (uk)	1997-02-28	Спосіб експресії мітогеhhого білка еhдотеліальhих клітиh людиhи
NZ279963A (en)	1998-10-28	Human tissue inhibitor of metalloproteinase-4 (timp-4) and dna (rna) encoding polypeptide which may be derived from atcc 75946
ATE226634T1 (de)	2002-11-15	Fibronektin bindendes protein
WO1998014596A3 (fr)	1998-08-20	Tyrosine phosphatases proteiques associees a des maladies
ATE264913T1 (de)	2004-05-15	Protease-resistente analoge des thrombomodulin
NZ331063A (en)	2000-03-27	Isolated nucleotide sequences encoding for mature LS- DNase which is resistant to actin inhibition
EP0815233A4 (fr)	1999-06-16	Nouvelles cytokines aviaires et sequences genetiques codant celles-ci
NZ303588A (en)	1999-02-25	Mpl ligand analogs having one or more changed glycosylation sites uses for these ligand analogs and dna sequences encoding them
MY101874A (en)	1992-01-31	Vaccine
ES8205429A1 (es)	1982-06-01	Procedimiento para la preparacion de un plasmido que codifica para la secuencia de aminoacidos del interferon de fibro- blastos humanos.
DE69730967D1 (en)	2004-11-04	Human dnase ii
DE69616288D1 (de)	2001-11-29	Nukleotid sequenzen und daraus abgleitete aminosäuresequenzen vom tumorgen int 6
ATE346920T1 (de)	2006-12-15	Neues immunoregulatorisches protein lst-1
GB8805799D0 (en)	1988-04-13	Csf-1 human nucleotide sequence used as gene promoter